3 Steps To Improve Site Acceptance Of ePRO In Medical Device Trials

By Melissa Newara, Senior Director, Subject Matter Expertise

In the next five years, it has been suggested that the adoption of electronic patient-reported outcome collection could help reduce the development time for medical devices by 25%. However, bringing ePRO into a study can be advantageous as many clinical sites already use over 20 IT systems, making integrating new solutions frustrating and complex.

While the process could be more straightforward, studies will only benefit if they are able to take the right approach and capitalize on ePRO. In the fast-paced medical device trials industry, projected to hit USD 964.90 billion by 2030, streamlining operations, minimizing trial fees, and improving data transparency are vital to secure a first-to-market position¹.

Discover how with the proper understanding of a site’s barriers, early engagement, and prioritizing effective training, site acceptance of ePRO can be improved.